Why Veru Stock Plummeted on Monday
Veru (NASDAQ: VERU) has found itself the target of a short-seller, and as a result the biotech company's shares took a more than 12% hit on an otherwise upbeat Monday for the wider stock market. That short-seller didn't mince words about its concerns with the company, which clearly left investors quite spooked about its future.
Culper Research, an activist short-seller that in its words "seek[s] to expose companies which have misrepresented their operations, failed to disclose significant risks, misappropriated capital, possess accounting irregularities, or otherwise deceived investors," published a blistering report on its short position in Veru.
Image source: Getty Images.
Source Fool.com
